* Surgepays Inc SURG.OQ SURG.O is expected to show a
fall in
quarterly revenue when it reports results on November 12 for
the period ending September 30 2024
* The Bartlett Tennessee-based company is expected to
report a
74.7% decrease in revenue to $8.642 million from $34.16 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Surgepays Inc is for a
loss
of 27 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Surgepays
Inc is
5.50, above its last closing price of $1.52.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -0.09 -0.07 -0.66 Missed -842.9
Jan. 1 2024 0.14 0.15 0.07 Missed -53.3
Dec. 31 2023 0.41 0.41 0.19 Missed -53.3
Sep. 30 2023 0.28 0.29 0.49 Beat 71.9
Jun. 0.15 0.16 0.40 Beat 158.1
30 2023
Mar. 31 2023 -0.03 -0.03 0.31 Beat 1,133.
3
Dec. 31 2022 -0.19 -0.11 0.25 Beat 317.4
Jan. 1 0001 0.29 0.29 -0.12 Missed -141.4
This summary was machine generated November 9 at 00:43 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)